Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action
Koethe, S.M.; Austen, K.F.; Gigli, I.
Journal of Immunology 110(2): 390-400
1973
ISSN/ISBN: 0022-1767 PMID: 4684033 Accession: 042403687
PDF emailed within 1 workday: $29.90
Related References
Kerr, M.A.; Parkes, C. 1984: The effects of iodine and thiol blocking reagents on complement c 2 and on the assembly of the classical pathway complement c 3 convertase Biochemical Journal 219(2): 391-400Garcia, B.L.; Zhi, H.; Wager, B.; Höök, M.; Skare, J.T. 2016: Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex Plos Pathogens 12(1): E1005404
Buerke, M.; Prüfer, D.; Dahm, M.; Oelert, H.; Meyer, J.; Darius, H. 1998: Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury Journal of Pharmacology and Experimental Therapeutics 286(1): 429-438
Loos, M. 1982: The classical complement pathway mechanism of activation of complement c 1 by antigen antibody complexes Kallos, P (Ed ) Progress in Allergy, Vol 30 Recent Trends in Allergen And Complement Research Xiv+234p S Karger: Basel, Switzerland; New York, N Y , Usa Illus P135-192
Anderson, J.B.; Smith, S.A.; van Wijk, R.; Chien, S.; Kotwal, G.J. 2003: Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation Transplant Immunology 11(2): 129-135
Ziccardi, R.J. 1981: Specific complement c 1 dissociation immunoassays as an indicator for classical pathway activation of complement and complement c 1 inactivator function Nakamura, R M , W R Dito And E S Tucker Iii (Ed ) Laboratory And Research Methods in Biology And Medicine, Vol 4 Immunoassays: Clinical Laboratory Techniques For The 1980s; Proceedings Of The 2nd Annual Conference on Immunoassays in The Clinical Laboratory, San Diego, Calif , Usa, Feb 6-8, 1980 Xvii+464p Alan R Liss, Inc : New York, N Y , Usa Illus P433-442, 1980
Strunk, R.C.; Giclas, P.C. 1979: Control of human classical complement pathway complement c 3 convertase inhibition of complement c 3 cleavage by complement c 5 or cell bound complement c 3b Federation Proceedings 38(3 Part 1): 1011
Wang, T.; Secombes, C.J. 2003: Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss Immunogenetics 55(9): 615-628
Johannsen, R.; Enders, B.; Seiler, F.R. 1977: Hemolytic and lympholytic properties of f ab 2 fragments of antibodies activation of complement via the alternate pathway Zeitschrift fuer Immunitaetsforschung 153(4): 313-314
Kerr, M.A.; Parkes, C. 1984: The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase Biochemical Journal 219(2): 391-399
Jordon, R.E.; Schroeter, A.L.; Rogers, R.S.; Perry, H.O. 1974: Classical and alternate pathway activation of complement in pemphigus vulgaris lesions Journal of Investigative Dermatology 63(3): 256-259
Bishop, C.; Démant, P.; Capel, P.J. 1980: The blocking effect of antibodies against the products of the H-2 gene complex on lymphocyte complement (C3d) receptors. complement dependence and specificity Tissue Antigens 15(1): 31-39
Marinho, C.Ferreira.; Azeredo, E.Leal.; Torrentes-Carvalho, A.; Marins-Dos-Santos, A.; Kubelka, C.Fernandes.; de Souza, L.José.; Cunha, R.Venâncio.; de-Oliveira-Pinto, L.Maria. 2014: Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection Plos one 9(7): E102014
Gotze, O. 1972: Conversion of 3rd component of complement pro activator and activation of the alternate pathway of complement activation by different classes and subclasses of human immuno globulins Federation Proceedings 31: 655
Burge, J.; Nicholson, A.; Rowe, M.; Austen, K.F. 1979: Purification from guinea pig serum of a decay accelerating factor for the erythrocyte antibody guinea pig complement c 1 complement c 4 complement c 2 classical complement pathway complement c 3 convertase Federation Proceedings 38(3 Part 1): 1010
Goetze, O.; Mueller Eberhard, H.J. 1971: The 3rd component of complement activator system an alternate pathway of complement activation Journal of Experimental Medicine 134(3 Part 2): 90S-108S
Perry, H.; Bovin, N.; Henry, S. 2016: Antibody complement-mediated hemolytic studies with kodecytes reveal that human complement utilized in the classical pathway is more stable than generally accepted Transfusion 56(10): 2495-2501
Jordon, R.E.; Schroeter, A.L.; Good, R.A.; Day, N.K. 1975: The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation Clinical Immunology and Immunopathology 3(3): 307-314
Grant, J.A.; Lichtenstein, L.M. 1973: The role of complement in human immediate hypersensitivity: evidence against involvement of the alternate pathway of complement activation Journal of Immunology 111(3): 733-742
Hunsicker, L.G.; Ruddy, S.; Austen, K.F. 1973: Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3) Journal of Immunology 110(1): 128-138